Recent Finacing
Recent Raise
Santa Ana Bio uses proteomic, transcriptomic, and genomic profiling to identify disease-specific cell subpopulations and engineers monoclonal, bispecific, and antibody–drug/antibody–glucocorticoid conjugates with programs entering Phase I.
